They found that with a population of 48 patients with STXBP1 pathogenic variants and seizures, the earlier onset of seizures was correlated with worse developmental outcomes, while age at seizure remission or duration of epilepsy did not affect outcomes [21]. The gene discussed is STXBP1; the disease is epilepsy.